Read More

CHMP Issues Negative Opinion For Renewal Of Conditional Marketing Authorization For Translarna Following Re-Examination Procedure; Per European Regulations, The European Commission Has 67 Days To Adopt The Opinion

 PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a negative opinion following the re-examination

PTCT